In This Section

Program

Users can search and browse invited speaker sessions and proffered paper sessions through the online program planner.

View the Program Planner

Summaries of selected sessions from Cancer Research Catalyst, the official blog of the AACR, are available below.

Plenary Sessions

Saturday, April 15, 2023 | Read the Session Summary
Beating Kras: A 30-Year Overnight Sensation
Chair: Dafna Bar-Sagi, NYU Langone Health, New York, New York

  • Dafna Bar-Sagi, NYU Langone Health, New York, New York
  • Pasi A. Jänne, Dana-Farber Cancer Institute, Boston, Massachusetts
  • Beatriz M. Carreno, University of Pennsylvania, Philadelphia, Pennsylvania
  • Frank McCormick, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California

Sunday, April 16, 2023 | Read the Session Summary
Opening Plenary Session: Advancing the Frontiers of Cancer Science and Medicine
Chair: Robert H. Vonderheide, Penn Medicine Abramson Cancer Center, Philadelphia, Pennsylvania

  • Deborah Schrag, Memorial Sloan Kettering Cancer Center, New York, New York
  • David G. Denardo, Washington University School of Medicine in St. Louis, St. Louis, Missouri
  • Tomi Akinyemiju, Duke University School of Medicine, Durham, North Carolina
  • Robert Yarchoan, National Cancer Institute, Bethesda, Maryland
  • Teresa A. Zimmers, Oregon Health & Science University, Portland, Oregon

Monday, April 17, 2023 | Read the Session Summary
Early Detection and Interception of Cancer
Chair: Peter Kuhn, University of Southern California, Los Angeles, California

  • Phil H. Jones, Wellcome Sanger Institute, Cambridge, United Kingdom
  • Eun-Sil Shelley Hwang, Duke Cancer Institute, Durham, North Carolina
  • Phillip G. Febbo, Illumina Inc., San Diego, California
  • Elana J. Fertig, Johns Hopkins University, Baltimore, Maryland
  • Karriem S. Watson, National Institutes of Health, Bethesda, Maryland

Tuesday, April 18, 2023 | Read the Session Summary
Embracing Immune Ecosystems
Chair: Judith A. Varner, UCSD Moores Cancer Center, La Jolla, California

  • Miriam Merad, Icahn School of Medicine at Mount Sinai, New York, New York
  • Florent Ginhoux, Gustave Roussy, Villejuif, France
  • Dario A. Vignali, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
  • Gianpietro Dotti, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
  • Jose R. Conejo-Garcia, Duke University, Durham, North Carolina
  • Judith A. Varner, UCSD Moores Cancer Center, La Jolla, California

Wednesday, April 19, 2023 | Read the Session Summary
New Concepts in Drug Discovery and Engineering
Chair: Sanjay V. Malhotra, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon

  • Jennifer R. Cochran, Stanford University, Stanford, California
  • Andrea L. Kasinski, Purdue University, West Lafayette, Indiana
  • Gregory R. Bowman, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
  • Evan A. Scott, Northwestern University, Evanston, Illinois
  • Puja Sapra, AstraZeneca – MedImmune, LLC, Gaithersburg, Maryland

AACR Annual Meeting 2023 Highlights: Vision for the Future | Read the Session Summary
Chair: Robert H. Vonderheide, Penn Medicine Abramson Cancer Center, Philadelphia, Pennsylvania

  • Sheila A. Stewart, Washington University in St. Louis, St. Louis, Missouri
  • Elizabeth A. Platz, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
  • Shivaani Kummar, OHSU Knight Cancer Institute, Portland, Oregon

Major Symposia

  • 25th Anniversary of Trastuzumab: Impact and Future Directions
  • Addressing the Global Oncology Disease Burden
  • Advances in Quantitative Sciences in Cancer: From Atomic Scale to Patients
  • Advances in Supportive Care
  • Artificial Intelligence at the Interface of Sparse Clinical Data and Big Laboratory Data
  • Biological Basis of Novel Targets for Solid Tumors
  • The Biology of Obesity, Aging, and Nutrition
  • Cancer Ecosystem and the Microenvironment
  • Cancer Stem Cells and Immuno-oncology
  • CAR T Cells in Solid Tumors
  • Cellular Therapies for Cancer
  • Clinical Opportunities and Challenges with Liquid Biopsies
  • Clinical Strategies for Myeloid Cell Modulation in Cancer
  • Complicity of Benign Cells in the Tumor Microenvironment
  • The Connection between Autoimmunity and Immunotherapy in Cancer
  • DNA Damage and Therapeutic Strategies
  • Electronic Health Records and Cancer Learning Health Systems
  • Future of Phase I Clinical Trials
  • Histone Alterations and Epigenetics as Cancer Drivers
  • Humoral Immune Response and Tertiary Lymphoid Structures in Cancer
  • Immunometabolism in the Tumor Microenvironment
  • Impact of Clonal Hematopoiesis in Cancer
  • Innate Lymphocytes and Cancer
  • Metabolic Influence on the Cancer Cell State
  • Microbiome and Cancer Immunotherapy
  • Molecular Mechanisms of KRAS Pathway Inhibitors
  • Myeloid Cells and Biological Responses in Cancer
  • New Horizons for T Cell Immunity and Checkpoints
  • New Insights into Cancer Initiation, Progression, and Therapy through Big Data Resources
  • Organ-Specific Regulation of Metastasis
  • Overcoming Drug Resistance
  • Pathogenesis of Childhood Cancers
  • Presidential Select Symposium: Pregnancy and Cancer
  • Radiation Therapy, DNA Damage, and Immune Response
  • RNA and the Cancer Transcriptome
  • Role of Aging in Cancer
  • Sex Hormones and Cancer
  • Spatial Technologies for Mapping Cancer Cell Architecture
  • Stress, Stemness, and Drug Resistance
  • Systemic Effects of Cancer
  • T Cells and the Tumor
  • Tumor Glycome in Metastasis, Immune Suppression, and Drug Resistance

Advances in Diagnostics and Therapeutics

  • Advances in FLASH Radiation
  • Cancer Vaccines: Back to the Future
  • Early Detection of Cancer and the Science of Early Cancer
  • Functional Precision Medicine
  • Immune Profiling and Immune Health in Cancer
  • Multiomics in Diagnosis and Care Management
  • New Approaches to Early Detection
  • Novel Computational Tools to Probe Cancer at the Single Cell Level
  • Novel Drug Design and Engineering
  • Surgical Advances with Chemical Probes and Intraoperative Imaging

Advances in Organ Site Research

  • Advances in Breast Cancer
  • Advances in Brain Tumors
  • Advances in Gastrointestinal Malignancies
  • Advances in Leukemia Research and Treatment
  • Advances in Lymphoma
  • Advances in Melanoma Research and Treatment
  • Advances in Non–Small Cell Lung Cancer
  • Advances in Ovarian Cancer
  • Advances in Pancreas Cancer
  • Advances in Prostate Cancer
  • Advances in Sarcoma Biology
  • Advances in Small Cell Lung Cancer and Neuroendocrine Cancer

Advances in Population Sciences

  • Behavioral Economics and Psychology to Improve Cancer Care
  • Cancer and COVID-19 Vaccination
  • Population Sciences in the Era of Omics

Advances in Prevention Research

  • Advances in Cancer Screening and Prevention
  • Germline Genetics and Cancer Predisposition
  • The Science Driving Novel Treatment of Nicotine Addiction
  • Strategies for Cancer Interception

Advances in the Science of Cancer Disparities

  • Achieving Equitable Access to Cancer Care
  • Disparities and Cancer Outcomes
  • The Biology Driving Cancer Disparities

Forums

  • CAR Cells: Which CAR to Drive?
  • Has Adding Anti-PD1/PDL1 to Other Treatments Lived Up to the Hope?
  • How Can We Improve Data-Sharing?
  • How Can We Improve Workforce Recruitment and Retention?
  • How Can We Make Cancer Care at Home the Norm and Not the Exception?
  • What Are the Challenges and Solutions in Adolescent and Young Adult Cancers?
  • What Does a Biostatistician Really Think of Your Study and Why?
  • What Is the Best Way to Engage Diverse Communities in Cancer Research?
  • What is the Future of Antiangiogenesis?
  • What Is the Utility of PDX and Organoid Models in the Era of Immuno-oncology?